324 related articles for article (PubMed ID: 22429463)
1. Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients.
Román-Pérez E; Casbas-Hernández P; Pirone JR; Rein J; Carey LA; Lubet RA; Mani SA; Amos KD; Troester MA
Breast Cancer Res; 2012 Mar; 14(2):R51. PubMed ID: 22429463
[TBL] [Abstract][Full Text] [Related]
2. High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes.
Riaz M; Sieuwerts AM; Look MP; Timmermans MA; Smid M; Foekens JA; Martens JW
Breast Cancer Res; 2012 Sep; 14(5):R123. PubMed ID: 22967435
[TBL] [Abstract][Full Text] [Related]
3. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma.
Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE
Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274
[TBL] [Abstract][Full Text] [Related]
4. JNK1 stress signaling is hyper-activated in high breast density and the tumor stroma: connecting fibrosis, inflammation, and stemness for cancer prevention.
Lisanti MP; Tsirigos A; Pavlides S; Reeves KJ; Peiris-Pagès M; Chadwick AL; Sanchez-Alvarez R; Lamb R; Howell A; Martinez-Outschoorn UE; Sotgia F
Cell Cycle; 2014; 13(4):580-99. PubMed ID: 24434780
[TBL] [Abstract][Full Text] [Related]
5. Relationship of mammographic density and gene expression: analysis of normal breast tissue surrounding breast cancer.
Sun X; Gierach GL; Sandhu R; Williams T; Midkiff BR; Lissowska J; Wesolowska E; Boyd NF; Johnson NB; Figueroa JD; Sherman ME; Troester MA
Clin Cancer Res; 2013 Sep; 19(18):4972-4982. PubMed ID: 23918601
[TBL] [Abstract][Full Text] [Related]
6. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ.
Sharma M; Beck AH; Webster JA; Espinosa I; Montgomery K; Varma S; van de Rijn M; Jensen KC; West RB
Breast Cancer Res Treat; 2010 Sep; 123(2):397-404. PubMed ID: 19949854
[TBL] [Abstract][Full Text] [Related]
7. Expression and significance of Twist, estrogen receptor, and E-cadherin in human breast cancer cells and tissues.
Tan R; Wang L; Song J; Li J; He T
J Cancer Res Ther; 2017; 13(4):707-714. PubMed ID: 28901319
[TBL] [Abstract][Full Text] [Related]
8. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
9. ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix.
Wang Y; Lu S; Xiong J; Singh K; Hui Y; Zhao C; Brodsky AS; Yang D; Jolly G; Ouseph M; Schorl C; DeLellis RA; Resnick MB
J Pathol Clin Res; 2019 Jan; 5(1):40-52. PubMed ID: 30207088
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion.
Shaker H; Bundred NJ; Landberg G; Pritchard SA; Albadry H; Nicholson SL; Harries LJ; Heah JYE; Castle J; Kirwan CC
Cancer Med; 2020 Mar; 9(5):1768-1778. PubMed ID: 31962001
[TBL] [Abstract][Full Text] [Related]
11. Matrix stiffness drives epithelial-mesenchymal transition and tumour metastasis through a TWIST1-G3BP2 mechanotransduction pathway.
Wei SC; Fattet L; Tsai JH; Guo Y; Pai VH; Majeski HE; Chen AC; Sah RL; Taylor SS; Engler AJ; Yang J
Nat Cell Biol; 2015 May; 17(5):678-88. PubMed ID: 25893917
[TBL] [Abstract][Full Text] [Related]
12. Tamoxifen therapy improves overall survival in luminal A subtype of ductal carcinoma in situ: a study based on nationwide Korean Breast Cancer Registry database.
Hwang KT; Kim EK; Jung SH; Lee ES; Kim SI; Lee S; Park HK; Kim J; Oh S; Kim YA;
Breast Cancer Res Treat; 2018 Jun; 169(2):311-322. PubMed ID: 29383628
[TBL] [Abstract][Full Text] [Related]
13. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.
Knudsen ES; Ertel A; Davicioni E; Kline J; Schwartz GF; Witkiewicz AK
Breast Cancer Res Treat; 2012 Jun; 133(3):1009-24. PubMed ID: 22134623
[TBL] [Abstract][Full Text] [Related]
14. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
[TBL] [Abstract][Full Text] [Related]
15. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and functional role of subtype-specific tumor-stroma interaction in breast cancer.
Merlino G; Miodini P; Callari M; D'Aiuto F; Cappelletti V; Daidone MG
Mol Oncol; 2017 Oct; 11(10):1399-1412. PubMed ID: 28672102
[TBL] [Abstract][Full Text] [Related]
17. Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.
Agosto-Arroyo E; Isayeva T; Wei S; Almeida JS; Harada S
Cancer Control; 2017 Jan; 24(1):102-110. PubMed ID: 28178722
[TBL] [Abstract][Full Text] [Related]
18. Tumor intrinsic subtype is reflected in cancer-adjacent tissue.
Casbas-Hernandez P; Sun X; Roman-Perez E; D'Arcy M; Sandhu R; Hishida A; McNaughton KK; Yang XR; Makowski L; Sherman ME; Figueroa JD; Troester MA
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):406-14. PubMed ID: 25465802
[TBL] [Abstract][Full Text] [Related]
19. Molecular profiling of microinvasive breast cancer microenvironment progression.
Lessi F; Scatena C; Aretini P; Menicagli M; Franceschi S; Naccarato AG; Mazzanti CM
J Transl Med; 2019 Jun; 17(1):187. PubMed ID: 31159827
[TBL] [Abstract][Full Text] [Related]
20. Co-expression modules identified from published immune signatures reveal five distinct immune subtypes in breast cancer.
Amara D; Wolf DM; van 't Veer L; Esserman L; Campbell M; Yau C
Breast Cancer Res Treat; 2017 Jan; 161(1):41-50. PubMed ID: 27815749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]